(Q44518862)

3 December 2017

title

Abciximab inhibits procoagulant activity but not the release reaction upon collagen- or clot-adherent platelets (English)

1 reference

3 December 2017

S Ilveskero

1

1 reference

3 December 2017

R Lassila

series ordinal

2

1 reference

3 December 2017

publication date

1 April 2003

1 reference

Journal of Thrombosis and Haemostasis

3 December 2017

published in

1 reference

3 December 2017

volume

1

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

805-813

1 reference

Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Activation of the platelet collagen receptor integrin alpha(2)beta(1): its mechanism and participation in the physiological functions of platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Expression of Markers of Platelet Activation and the Interpatient Variation in Response to Abciximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Procoagulant activity on platelets adhered to collagen or plasma clot

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Networking in the hemostatic system. Integrin alphaiibbeta3 binds prothrombin and influences its activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00136.X

10.1046/J.1538-7836.2003.00136.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference